117 related articles for article (PubMed ID: 8233090)
1. Parvalbumin-immunoreactive dystrophic neurites and aberrant sprouts in the cerebral cortex of patients with Alzheimer's disease.
Ferrer I; Zújar MJ; Rivera R; Soria M; Vidal A; Casas R
Neurosci Lett; 1993 Aug; 158(2):163-6. PubMed ID: 8233090
[TBL] [Abstract][Full Text] [Related]
2. Differential incorporation of processes derived from different classes of neurons into senile plaques in Alzheimer's disease.
Adams LA; Munoz DG
Acta Neuropathol; 1993; 86(4):365-70. PubMed ID: 8256587
[TBL] [Abstract][Full Text] [Related]
3. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease.
Hof PR; Cox K; Young WG; Celio MR; Rogers J; Morrison JH
J Neuropathol Exp Neurol; 1991 Jul; 50(4):451-62. PubMed ID: 2061713
[TBL] [Abstract][Full Text] [Related]
4. The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease.
Sampson VL; Morrison JH; Vickers JC
Exp Neurol; 1997 May; 145(1):295-302. PubMed ID: 9184132
[TBL] [Abstract][Full Text] [Related]
5. Evidence that transmitter-containing dystrophic neurites precede those containing paired helical filaments within senile plaques in the entorhinal cortex of nondemented elderly and Alzheimer's disease patients.
Benzing WC; Brady DR; Mufson EJ; Armstrong DM
Brain Res; 1993 Aug; 619(1-2):55-68. PubMed ID: 7690677
[TBL] [Abstract][Full Text] [Related]
6. Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex.
Quigley BJ; Kowall NW
Neuroscience; 1991; 41(1):41-60. PubMed ID: 1711654
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of neurofibrillary tangles in parvalbumin-immunoreactive interneurones in the cerebral cortex of Alzheimer-type dementia brain.
Iwamoto N; Emson PC
Neurosci Lett; 1991 Jul; 128(1):81-4. PubMed ID: 1717900
[TBL] [Abstract][Full Text] [Related]
8. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease.
Hof PR; Nimchinsky EA; Celio MR; Bouras C; Morrison JH
Neurosci Lett; 1993 Apr; 152(1-2):145-8. PubMed ID: 8515868
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain.
Wang D; Munoz DG
J Neuropathol Exp Neurol; 1995 Jul; 54(4):548-56. PubMed ID: 7602328
[TBL] [Abstract][Full Text] [Related]
10. Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob disease.
Ferrer I; Casas R; Rivera R
Ann Neurol; 1993 Dec; 34(6):864-6. PubMed ID: 8250537
[TBL] [Abstract][Full Text] [Related]
11. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.
Dickson TC; King CE; McCormack GH; Vickers JC
Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781
[TBL] [Abstract][Full Text] [Related]
13. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
Thal DR; Härtig W; Schober R
J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
[TBL] [Abstract][Full Text] [Related]
14. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752
[TBL] [Abstract][Full Text] [Related]
15. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
Su JH; Cummings BJ; Cotman CW
Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
[TBL] [Abstract][Full Text] [Related]
16. Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase.
Pérez-Gracia E; Torrejón-Escribano B; Ferrer I
Acta Neuropathol; 2008 Sep; 116(3):261-8. PubMed ID: 18629521
[TBL] [Abstract][Full Text] [Related]
17. [Neuritic degeneration in Alzheimer-type dementia, with special reference to the presence of dark neurites].
Ikeda K
No To Shinkei; 1992 May; 44(5):449-55. PubMed ID: 1520565
[TBL] [Abstract][Full Text] [Related]
18. Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis.
Ferrer I; Tuñón T; Serrano MT; Casas R; Alcántara S; Zújar MJ; Rivera RM
J Neurol Neurosurg Psychiatry; 1993 Mar; 56(3):257-61. PubMed ID: 8459241
[TBL] [Abstract][Full Text] [Related]
19. A case of primary progressive aphasia with abnormally ubiquitinated neurites in the cerebral cortex.
Kinoshita A; Tomimoto H; Tachibana N; Suenaga T; Kawamata T; Kimura T; Akiguchi I; Kimura J
Acta Neuropathol; 1996 Nov; 92(5):520-4. PubMed ID: 8922065
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease.
Woodhouse A; Vickers JC; Dickson TC
Acta Neuropathol; 2006 Oct; 112(4):429-37. PubMed ID: 16855832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
